Identifying Demographic and Clinical Determinants of Ischemic Workup in Patients with Heart Failure

Heart Failure

Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial

PLoS One

Bitos K, Laptseva N, Haider T, Rossi VA, Nägele MP, Barthelmes J, Ruschitzka F, Sudano I, Flammer AJ

doi: 10.1371/journal.pone.0325668

Heart Failure

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation

Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, Bellavia A, Kuder JF, Desai AS, Inzucchi SE, McMurray JJV, O'Meara E, Verma S, Bělohlávek J, Drożdż J, Merkely B, Ogunniyi MO, Drasnar T, Izzo JL, Sarman B, McGinty JE, Ramanathan K, Mulkay AJ, Przybylski A, Ruff CT, O'Donoghue ML, Murphy SA, Sabatine MS, Wiviott SD, DAPA ACT HF-TIMI 68 Trial Committees and Investigators

doi: 10.1161/CIRCULATIONAHA.125.076575

Heart Failure

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Eur J Heart Fail

Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C

doi: 10.1002/ejhf.3565

Heart Failure

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Eur J Heart Fail

Gorenek B, Wijnmaalen AP, Goette A, Mert GO, Porter B, Gustafsson F, Dan GA, Ector J, Stuehlinger M, Spartalis M, Gosau N, Amir O, Chioncel O

doi: 10.1002/ejhf.3645

Heart Failure

Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction

Eur J Heart Fail

Monzo L, Bresso E, Dickstein K, Pitt B, Cleland JGF, Anker SD, Lam CSP, Mehra MR, van Veldhuisen DJ, Greenberg B, Zannad F, Girerd N

doi: 10.1002/ejhf.3547

Heart Failure

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

Eur J Heart Fail

Ameri P, Costa P, Benson L, Stolfo D, Sayour NV, Ljungman C, Butler J, Anker SD, Girerd N, Keramida K, Filippatos G, Lund LH, Lindberg F, Savarese G

doi: 10.1002/ejhf.3775

Heart Failure

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

ESC Heart Fail

Alonso Salinas GL, Martínez León A, Aguiar Cano D, Esteban-Fernández A, Viéitez Flórez JM, Del Prado Díaz S, Górriz-Magaña J, de Lara Delgado G, González-Manzanares R, Caravaca-Pérez P, Pastor-Pérez FJ, Valdivieso-Moré S, Quiles J, Ponz I, Escolar V, Boada Lincango EO, Báez-Ferrer N, Gallego G, Almenar L, Gutiérrez de la Varga L, Codina P, Recio Mayoral A, Fort A, Pinilla Lozano MJ, González-Calle D, Gómez-Otero I, Salazar Mosteiro C, Cobo M, Piqueras-Flores J, Bonanad C, Huerta A, Ferré Vallverdú M, Díez-Villanueva P

doi: 10.1002/ehf2.15260

ESC 2025

Heart Failure

Treating heart failure patients with anti-obesity medication reduces greenhouse gas emissions and improves clinical outcomes

Heart Failure

Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

Eur J Heart Fail

Adamo M, Pagnesi M, Chioncel O, Bayes-Genis A, Abdelhamid M, Antohi EL, Bucciarelli-Ducci C, Chieffo A, Cosyns B, Gilard M, Grapsa J, González A, Gustafsson F, Iung B, Joner M, Karam N, Lund LH, Maisano F, Moura B, Praz F, Rudolph TK, Sannino A, Savarese G, Tocchetti CG, Van Empel VPM, Volterrani M, Windecker S, Ponikowski P, Rosano GMC, Barbato E, Metra M

doi: 10.1002/ejhf.70023

Related content

Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction

Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

Treating heart failure patients with anti-obesity medication reduces greenhouse gas emissions and improves clinical outcomes

Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC